Information is sparse on the burden of healthcare resource utilization (HCRU) and costs among patients with negative symptoms of schizophrenia (NSS). Using a retrospective longitudinal ob...
The prevalence of concomitant medication use in patients with schizophrenia has not been well established. This study aimed to bridge this gap by evaluating the annual prevalence of conco...